在霍奇金淋巴瘤中基于抗体的疗法
Vivek S Radhakrishnan1, Jemma Longley2, Peter W M Johnson2
1Department of Medical Oncology, University Hospital Southampton NHS Trust, Southampton, UK.
Cancer treatment reviews
|November 21, 2023
概括
霍奇金淋巴瘤是高度可治愈的,但治疗耐药性和副作用仍然存在. 新型免疫疗法,包括基于抗体的治疗方法和免疫检查点抑制剂,有望克服这些挑战,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 由于多模式治疗策略,霍奇金淋巴瘤 (HL) 越来越容易治愈.
- 仍然存在重大挑战,包括治疗耐药性 (耐药性/复发性疾病) 和与治疗相关的毒性.
- 了解HL生物学和翻译医学的进步正在推动治疗创新.
研究的目的:
- 审查霍奇金淋巴瘤免疫疗法的当前情况.
- 突出瘤抗原导向疗法和免疫检查点抑制剂.
- 讨论这些新方法如何解决HL治疗中未得到满足的需求.
主要方法:
- 关于霍奇金淋巴瘤治疗近期进展的文献综述.
- 专注于免疫治疗策略,包括基于抗体的疗法和免疫检查点抑制剂.
- 分析表明改善患者结果和克服耐药性的研究.
主要成果:
- 免疫疗法,特别是基于抗体的治疗方法,正在彻底改变HL的管理.
- 瘤抗原导向疗法和免疫检查点抑制剂在耐药和复发病例中显示出潜力.
- 这些新型药物为改善生存率和减少长期发病率提供了新的希望.
结论:
- 免疫疗法代表了对治疗霍奇金淋巴瘤的范式转变.
- 针对性免疫疗法对于解决耐药性和毒性至关重要.
- 对新型免疫治疗策略的持续研究对于进一步改善HL患者的治疗结果至关重要.
相关概念视频
01:27Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
01:31Hybridoma Technology
14.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.8K
01:36Humoral Immune Responses
72.8K
Overview
72.8K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:24B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K